Oculis Holding AG (FRA:CR5) FCF Margin %: 0.00% (As of Mar. 2026)


FRA:CR5 Oculis Holding AG FRA:CR5
35 GF Score
Price €11.00
! 1 Warning Sign
View Full Analysis

What is Oculis Holding AG FCF Margin %?

Oculis Holding AG FRA:CR5 +12.70% 35 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates FRA:CR5 with a GF Score™ of 35/100. The stock has 1 warning sign investors should review. Among 956 Biotechnology companies, Oculis Holding AG ranks worse than 104602.41% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Oculis Holding AG's Free Cash Flow for the three months ended in Mar. 2026 was €-16.86 Mil. Oculis Holding AG's Revenue for the three months ended in Mar. 2026 was €0.00 Mil. Therefore, Oculis Holding AG's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Oculis Holding AG's current FCF Yield % is -9.41%.

The historical rank and industry rank for Oculis Holding AG's FCF Margin % or its related term are showing as below:


FRA:CR5's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -85.21
* Ranked among companies with meaningful FCF Margin % only.

Oculis Holding AG FCF Margin % Related Terms

Oculis Holding AG FCF Margin % Historical Data

* Premium members only.

The historical data trend for Oculis Holding AG's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oculis Holding AG FCF Margin % Chart

Oculis Holding AG Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Oculis Holding AG Quarterly Data
Dec20 Sep21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:CR5 vs NVCT, AURA, CADL: FCF Margin % Comparison

For the Biotechnology subindustry, Oculis Holding AG's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oculis Holding AG FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oculis Holding AG's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Oculis Holding AG's FCF Margin % falls into.


FRA:CR5
35GF Score
Oculis Holding AG FRA:CR5
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oculis Holding AG FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Oculis Holding AG's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-72.542/0
= %

Oculis Holding AG's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-16.859/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Oculis Holding AG (FRA:CR5) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Oculis Holding AG and its competitors. According to the industry distribution chart, Oculis Holding AG ranks #999999 out of 956 companies in the Biotechnology industry.
Is Oculis Holding AG's FCF Margin % too high?
Oculis Holding AG's current FCF Margin % is 0.00%. Based on the distribution chart, Oculis Holding AG ranks #999999 out of 956 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Oculis Holding AG has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Oculis Holding AG's FCF Margin % compare to NVCT and AURA?
According to the Biotechnology industry distribution chart, Oculis Holding AG ranks #999999 out of 956 companies for FCF Margin %. This places Oculis Holding AG in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Oculis Holding AG and its competitors. Oculis Holding AG's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oculis Holding AG stock overvalued right now?
Oculis Holding AG (FRA:CR5) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Oculis Holding AG's overall GF Score™ is 35/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Oculis Holding AG (FRA:CR5), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oculis Holding AG Business Description

Address Bahnhofstrasse 20, Zug, CHE, CH-6300
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.
35GF Score

Get the complete analysis for FRA:CR5

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.00
Price